DoH Policies screened during the period: 1 April 2016 to 30 June 2016

In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact assessment (EQIA).

Documents

NICE (Public Health) Guideline – PH56 - Vitamin D: increasing supplement use among at-risk groups
PDF (273 KB)

NICE (Clinical) Guideline NG41 – Spinal injury: assessment and initial management
PDF (273 KB)

NICE (Clinical) Guideline NG40 – Major trauma: service delivery
PDF (275 KB)

NICE (Clinical) Guideline NG39 - Major trauma: assessment and initial management
PDF (287 KB)

NICE (Clinical) Guideline NG 38 - Fractures (non-complex): assessment and management
PDF (274 KB)

NICE (Clinical) Guideline NG 37 - Fractures (complex): assessment and management
PDF (274 KB)

NICE Technology Appraisal TA20 - Riluzole (Rilutek) for the treatment of Motor Neurone Disease
PDF (273 KB)

NICE (Clinical) Guideline NG42 - Motor neurone disease: assessment and management
PDF (273 KB)

NICE (Public Health) Guideline – NG44 - Community engagement: improving health and wellbeing and reducing health inequalities
PDF (268 KB)

NICE Guideline NG35 - Myeloma: diagnosis and management
PDF (266 KB)

NICE (Clinical) Guideline CG72 – Attention deficit hyperactivity disorder: diagnosis and management – Addendum
PDF (270 KB)

NICE (Clinical) Guideline NG36 – Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over
PDF (267 KB)

NICE (Public Health) Guideline – PH35 - Type 2 diabetes prevention: population and community-level interventions
PDF (272 KB)

NICE (Public Health) Guideline – NG16 - Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset
PDF (271 KB)

NICE Guideline NG 33 – Tuberculosis
PDF (269 KB)

NICE (Public Health) Guideline – NG34 - Sunlight exposure: risks and benefits
PDF (277 KB)

NICE (Public Health) Guideline – NG13 - Workplace health: management practices
PDF (273 KB)

NICE Technology Appraisal TA 98 - Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
PDF (271 KB)

NICE Clinical Guideline NG45 - Routine preoperative tests for elective surgery
PDF (268 KB)

NICE Technology Appraisal TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
PDF (271 KB)

NICE Technology Appraisal TA388 - Sacubitril valsartan for treating heart failure with systolic dysfunction
PDF (271 KB)

NICE Technology Appraisal TA 386 - Ruxolitinib for treating related splenomegaly or symptoms in adults with myelofibrosis
PDF (283 KB)

NICE Technology Appraisal NICE TA 23 - Temozolomide for the treatment of recurrent malignant glioma (brain cancer)
PDF (268 KB)

NICE (Clinical) Guideline CG32 - Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition
PDF (267 KB)

NICE Clinical Guideline CG97 - Lower urinary tract symptoms in men: assessment and management – Addendum
PDF (271 KB)

NICE (Public Health) Guideline – PH38 - Type 2 diabetes: prevention in people at high risk
PDF (271 KB)

NICE Technology Appraisal TA 391 - Cabazitaxel for hormone relapsed metastatic prostate cancer treated with docetaxel (review of TA255)
PDF (270 KB)

NICE (Public Health) Guideline – NG30 - Oral health promotion: general dental practice
PDF (270 KB)

NICE (Public Health) Guideline – PH55 - Oral health: local authorities and partners
PDF (270 KB)

NICE Technology Appraisal TA 390 - Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
PDF (268 KB)

National Statistics – proposed changes to DHSSPS statistical publications
PDF (423 KB)

Standards for Supported Lodgings for Young Adults (aged 16-21) in Northern Ireland
PDF (905 KB)

The remodelling of the administrative structures of the Health and Social Care system
PDF (935 KB)

Consideration Stage amendments to the Mental Capacity Bill
PDF (337 KB)

Help viewing documents